LONDON – 1 October 2025: Camarco, APCO’s capital markets group, announces the launch of a dedicated financial advisory offer to companies in the health sector, led by newly appointed Head of Health Sukaina (Suki) Virji, PhD. The new offering leverages Camarco’s market-leading financial communications expertise alongside APCO’s extensive global health network to serve pharmaceutical, biotechnology, medical technology, health services companies and specialist investors.
The offering will support the full spectrum of health-focused companies at all stages of development, providing strategic financial communications, investor relations, capital markets advisory, M&A communications, crisis management and regulatory communications support.
Virji joins as head of Health, Camarco, following almost a decade at a financial PR agency specialising in advising companies in the health sector, where she led multiple pharmaceutical, biotechnology and medical technology accounts for both listed and private companies. Virji, who holds a PhD in biochemistry and molecular biology from University College London, previously worked for more than 15 years as a trade journalist on leading health-focused business publications, covering R&D, clinical trial outcomes, regulatory updates, partnering activity, M&A deals, private financings and IPOs.
“The health sector represents one of the most dynamic and important areas of the global economy, with companies requiring sophisticated financial communications support as they navigate complex regulatory environments, capital raising activities and investor relations,” said Geoffrey Pelham-Lane, CEO of Camarco and chairman of APCO in the UK. “Suki’s unique combination of deep scientific expertise, extensive journalism background and proven communications advisory skills makes her ideally positioned to lead our health offering. Combined with Camarco’s established excellence in financial PR and APCO’s market-leading global health practice, we’re perfectly positioned to serve this critical sector.”